References

Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8Å

10.1016/0022-2836(78)90368-6 · 1978 · External reference

Three-dimensional structure of the transthyretin-retinol-binding protein complex

10.1515/cclm.2002.213 · 2002 · External reference

Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling

10.1016/j.pneurobio.2003.11.002 · 2003 · External reference

Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy

10.1074/jbc.m602302200 · 2006 · External reference

Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type

1983 · External reference

Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. II. Nerve fibre changes

10.1093/brain/94.2.207 · 1971 · External reference

Tafamidis

10.1038/nrd3675 · 2012 · External reference

Transthyretin-related amyloidoses and the heart: a clinical overview

10.1038/nrcardio.2010.67 · 2010 · External reference

Alzheimer’s disease: the amyloid cascade hypothesis

10.1126/science.1566067 · 1992 · External reference

The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics

10.1126/science.1072994 · 2002 · External reference

Wanker EE EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers

10.1038/nsmb.1437 · 2008 · External reference

Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity

10.1016/j.febslet.2009.10.062 · 2009 · External reference

Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils

10.1021/bi2012383 · 2011 · External reference

How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitro

10.1074/jbc.m114.554667 · 2014 · External reference

Polyphenols as therapeutic molecules in Alzheimer’s disease through modulating amyloid pathways

2014 · External reference

Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism

10.1111/j.1747-0285.2005.00318.x · 2006 · External reference

Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity

10.1021/bi00096a024 · 1993 · External reference

Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative

10.1042/bj20040011 · 2004 · External reference

Specific detection of quinoproteins by redox-cycling staining

10.1016/s0021-9258(17)35225-0 · 1991 · External reference

Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients

10.1002/(sici)1522-2683(19990601)20:7<1349::aid-elps1349>3.0.co;2-5 · 1999 · External reference

Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation

10.1016/j.febslet.2011.06.030 · 2011 · External reference

Comparative in vitro and ex vivo activities of selected inhibitors of transthyretin aggregation: relevance in drug design

10.1042/bj20070689 · 2007 · External reference

Covalent modification of proteins by green tea polyphenol [-]-epigallocatechin-3-gallate through autoxidation

10.1016/j.freeradbiomed.2008.07.023 · 2008 · External reference

Transthyretin oligomers induce calcium influx via voltage-gated calcium channels

10.1111/j.1471-4159.2006.04210.x · 2007 · External reference

Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates

10.1016/s0002-9440(10)63050-7 · 2001 · External reference

Recent advances in transthyretin amyloidosis therapy

10.1186/2047-9158-3-19 · 2014 · External reference

Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro

10.1016/j.bbadis.2004.06.008 · 2004 · External reference

Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis

10.1073/pnas.0501609102 · 2005 · External reference

Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP

10.1111/j.1471-4159.2008.05611.x · 2008 · External reference

The crystal structure of the green tea polyphenol [-]-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site

10.1021/bi1004409 · 2010 · External reference

Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity

10.1111/j.1460-9568.2005.04532.x · 2006 · External reference

Radical scavenging activity of tea catechins and their related compounds

10.1271/bbb.63.1621 · 1999 · External reference

Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2)

10.1038/sj.bjc.6600295 · 2002 · External reference

Structure-activity relationship of bis-galloyl derivatives related to [-]-epigallocatechin gallate

10.1248/cpb.57.190 · 2009 · External reference

Generation of mouse monoclonal antibody against (-)-epigallocatechin gallate

10.1248/bpb.31.816 · 2008 · External reference

Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases

10.1111/j.1755-5949.2008.00060.x · 2008 · External reference

Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies

10.1093/ajcn/81.1.230s · 2005 · External reference

Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans

10.1021/jf9032975 · 2010 · External reference

Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises?

10.3390/ijms12095592 · 2011 · External reference

Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate

10.1016/j.ejps.2010.06.010 · 2010 · External reference

Design, semisynthesis, and evaluation of O-acyl derivatives of (-)-epigallocatechin-3-gallate as antitumor agents

10.1021/jf070519f · 2007 · External reference

Piperine enhances thebioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice

10.1093/jn/134.8.1948 · 2004 · External reference

Parkinson’s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake

10.1093/aje/155.8.732 · 2002 · External reference

Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice

10.1523/jneurosci.1521-05.2005 · 2005 · External reference

Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties

10.1016/j.jnutbio.2012.06.011 · 2013 · External reference

Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: “in vivo” evidence from FAP mice models

10.1371/journal.pone.0029933 · 2012 · External reference

Green tea halts progression of cardiac transthyretin amyloidosis: an observational report

10.1007/s00392-012-0463-z · 2012 · External reference